Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10.
about
Association of cytokine gene polymorphisms with psoriasis in cases from the nile delta of egypt.Novel biological immunotherapies for psoriasis.Cytokine and anticytokine therapy in dermatology.Psoriasis and the new biologic agents: interrupting a T-AP danceInterleukin-10 in viral diseases and cancer: exiting the labyrinth?Novel pharmacological approaches in the treatment of psoriasis.PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia.Biologic agents in psoriasis.Emerging drugs for psoriasis.Regulatory B cells suppress imiquimod-induced, psoriasis-like skin inflammation.Anti-inflammatory mediators as physiological and pharmacological regulators of parturition.Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs.Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state.Pro-Inflammatory Signaling by IL-10 and IL-22: Bad Habit Stirred Up by Interferons?IL-10 implications in psoriasis.Scanning the Immunopathogenesis of Psoriasis.Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.Comprehensive biomarker monitoring in cytokine therapy: heterogeneous, time-dependent, and persisting immune effects of interleukin-10 application in psoriasis.
P2860
Q35095402-AE5D2B80-D48A-47E0-A405-0213D5B3751BQ35164740-E40984FE-8F61-4E1F-8AC2-F3C8AA9EFC31Q35184711-C04B27A9-A2F5-47E6-ADBF-361CDCCF4752Q35813465-3B286CFC-46B4-4355-B45F-C0319632E5A6Q35951835-F77D674C-AC0C-4C4C-907C-C55A1748A1DDQ36008673-5900277B-5BEF-4337-A42D-EF97B1898352Q36051650-D4A27F7E-8148-46C3-9B18-635166B48736Q36620700-19E4912B-3ED3-4E42-BF26-EE3F1F5C48A2Q36634244-01440E55-C963-4509-983C-B5DD76BDE6FFQ37176336-CC95864E-727A-47DF-BD4E-BD4B0DF229AFQ37927081-3DB55A31-3BFA-4BBF-8CAE-6290E83BB8E4Q38245677-F5A77859-4B1F-4199-9129-C47F70D0AF1CQ38693563-C4C4AAC9-21E4-4221-B558-A5907E818F95Q41999154-B930DE20-27A5-42E8-9F18-D83ACF73C2C5Q42079540-C18A713E-3F49-45EC-915B-AABDEA6DBD2AQ48278167-D85E536B-F09C-441F-A171-1B344804F987Q49276761-DAAC76B5-8F93-4B31-B5A0-FD2FE5A150B0Q52914437-1AEA133E-4C07-49DD-A70B-0FF1B0F6AD1B
P2860
Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical and immunologic asses ...... ombinant human interleukin 10.
@ast
Clinical and immunologic asses ...... ombinant human interleukin 10.
@en
Clinical and immunologic asses ...... ombinant human interleukin 10.
@nl
type
label
Clinical and immunologic asses ...... ombinant human interleukin 10.
@ast
Clinical and immunologic asses ...... ombinant human interleukin 10.
@en
Clinical and immunologic asses ...... ombinant human interleukin 10.
@nl
prefLabel
Clinical and immunologic asses ...... ombinant human interleukin 10.
@ast
Clinical and immunologic asses ...... ombinant human interleukin 10.
@en
Clinical and immunologic asses ...... ombinant human interleukin 10.
@nl
P2093
P1433
P1476
Clinical and immunologic asses ...... ombinant human interleukin 10.
@en
P2093
Alexa B Kimball
Ana R Hancox
Andrew Blauvelt
Carol Boss
Jonathan C Vogel
Krupali Tejura
Maria L Turner
Seth M Steinberg
Tatsuyoshi Kawamura
P304
P356
10.1001/ARCHDERM.138.10.1341
P577
2002-10-01T00:00:00Z